Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33000 participants
OBSERVATIONAL
2019-07-01
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fresh Versus Old Red Blood Cells for Transfusion
NCT01319552
Red Cell Storage Duration and Outcomes in Cardiac Surgery
NCT00458783
Adverse Effects of RBC Transfusions: A Unifying Hypothesis
NCT00838331
Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial
NCT01638416
Red Cell Storage Duration Study
NCT00991341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reference group
Transfused RBC stored 8-35 days
no intervention
This is an observational retrospective study (meta-analysis)
less than or equal 7 days
Transfused RBC stored =\<7 days
no intervention
This is an observational retrospective study (meta-analysis)
more than 7 days
Transfused RBC stored \<7 days
no intervention
This is an observational retrospective study (meta-analysis)
less that or equal 10 days
Transfused RBC stored =\<10 days
no intervention
This is an observational retrospective study (meta-analysis)
more that 10 days
Transfused RBC stored \>10 days
no intervention
This is an observational retrospective study (meta-analysis)
more than 35 days
Transfused RBC stored \>35 days
no intervention
This is an observational retrospective study (meta-analysis)
less than or equal 35 days
Transfused RBC stored =\<35 days
no intervention
This is an observational retrospective study (meta-analysis)
less than 18 days
Transfused RBC stored \<18 days
no intervention
This is an observational retrospective study (meta-analysis)
more than or equal 18 days
Transfused RBC stored =\>18 days
no intervention
This is an observational retrospective study (meta-analysis)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
This is an observational retrospective study (meta-analysis)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>=18 years of age
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie Steiner, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pending 4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.